Oncolytics Biotech Inc. (ONCY)
NASDAQ: ONCY · Real-Time Price · USD
0.867
-0.033 (-3.70%)
Apr 29, 2026, 10:18 AM EDT - Market open
Oncolytics Biotech Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 101 | 94 | 70 | 100 | 96 | 76 | |
| Market Cap Growth | 101.79% | 33.53% | -29.42% | 3.71% | 25.79% | -25.81% | |
| Enterprise Value | 100 | 86 | 57 | 71 | 73 | 39 | |
| Last Close Price | 0.90 | 0.87 | 0.91 | 1.35 | 1.63 | 1.39 | |
| PB Ratio | - | -24.76 | 21.36 | 4.78 | 4.91 | 2.68 | |
| P/TBV Ratio | - | - | 21.36 | 4.78 | 4.91 | 2.68 | |
| Debt / Equity Ratio | -0.15 | -0.15 | 0.23 | 0.02 | 0.01 | 0.02 | |
| Net Debt / Equity Ratio | 1.22 | 1.22 | -3.13 | -1.25 | -1.20 | -1.12 | |
| Net Debt / EBITDA Ratio | 0.16 | 0.16 | 0.41 | 1.02 | 1.18 | 1.56 | |
| Net Debt / FCF Ratio | 0.23 | 0.23 | 0.51 | 1.21 | 1.36 | 1.79 | |
| Quick Ratio | 0.95 | 0.95 | 2.28 | 8.24 | 8.15 | 15.37 | |
| Current Ratio | 1.12 | 1.12 | 2.55 | 9.01 | 9.05 | 16.69 | |
| Return on Equity (ROE) | - | - | -203.03% | -102.66% | -79.34% | -86.45% | |
| Return on Assets (ROA) | -170.96% | -170.96% | -79.03% | -55.46% | -40.44% | -40.88% | |
| Return on Capital Employed (ROCE) | -1939.60% | -1939.60% | -299.20% | -97.70% | -80.60% | -60.70% | |
| Earnings Yield | -27.50% | -30.58% | -32.36% | -21.06% | -19.07% | -27.18% | |
| FCF Yield | -19.24% | -21.39% | -28.48% | -21.59% | -17.98% | -23.47% | |
| Buyback Yield / Dilution | -25.33% | -25.33% | -13.10% | -16.53% | -8.44% | -32.66% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.